Title:
PHARMACEUTICAL COMPOSITION CONTAINING LANTHANUM CARBONATE
Document Type and Number:
Japanese Patent JP2019172610
Kind Code:
A
Abstract:
To provide a pharmaceutical composition containing lanthanum carbonate or a pharmaceutically acceptable salt thereof, which quickly disintegrates, has high hardness and has a good feeling of administration.SOLUTION: A pharmaceutical composition contains lanthanum carbonate or a pharmaceutically acceptable salt thereof and 0.2-4 mass% of a disintegrator, wherein the composition is disintegrated in an oral cavity with saliva or a small amount of water for oral administration.SELECTED DRAWING: None
More Like This:
| JP2023532768 | Therapeutic RNA for HPV-positive cancer |
| JP2018531234 | Quantification of Met protein for cancer treatment |
| JP2023505690 | replication protein A (RPA)-DNA interaction inhibitor |
Inventors:
KANBE HIDEYOSHI
AOYAGI FUMIYUKI
AOYAGI FUMIYUKI
Application Number:
JP2018062647A
Publication Date:
October 10, 2019
Filing Date:
March 28, 2018
Export Citation:
Assignee:
KOA ISEI CO LTD
International Classes:
A61K33/24; A61K9/20; A61K47/04; A61K47/12; A61K47/32; A61K47/36; A61K47/38; A61P3/12; A61P7/00; A61P13/12
Domestic Patent References:
| JP2017119655A | 2017-07-06 | |||
| JP2013067611A | 2013-04-18 | |||
| JP2010143836A | 2010-07-01 | |||
| JP6093829B1 | 2017-03-08 |
Foreign References:
| WO2017170763A1 | 2017-10-05 |
Attorney, Agent or Firm:
Patent business corporation Tsukuni